These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3469280)
1. Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex. Archibald DW; Barr CE; Torosian JP; McLane MF; Essex M J Infect Dis; 1987 Apr; 155(4):793-6. PubMed ID: 3469280 [No Abstract] [Full Text] [Related]
2. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Müller F; Frøland SS; Hvatum M; Radl J; Brandtzaeg P Clin Exp Immunol; 1991 Feb; 83(2):203-9. PubMed ID: 1899629 [TBL] [Abstract][Full Text] [Related]
3. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. Goudsmit J; Lange JM; Paul DA; Dawson GJ J Infect Dis; 1987 Mar; 155(3):558-60. PubMed ID: 3468176 [No Abstract] [Full Text] [Related]
4. Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. Archibald DW; Zon L; Groopman JE; McLane MF; Essex M Blood; 1986 Mar; 67(3):831-4. PubMed ID: 3484980 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations. Baillou A; Barin F; Allain JP; Petat E; Kocheleff P; Kadende P; Goudeau A J Infect Dis; 1987 Nov; 156(5):830-3. PubMed ID: 3477600 [No Abstract] [Full Text] [Related]
6. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Cartry O; Moja P; Quesnel A; Pozzetto B; Lucht FR; Genin C Clin Exp Immunol; 1997 Jul; 109(1):47-53. PubMed ID: 9218823 [TBL] [Abstract][Full Text] [Related]
7. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Sweet SP; Rahman D; Challacombe SJ Immunology; 1995 Dec; 86(4):556-9. PubMed ID: 8567021 [TBL] [Abstract][Full Text] [Related]
8. Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG. Klasse J; Blomberg J J Infect Dis; 1987 Dec; 156(6):1026-30. PubMed ID: 3479499 [No Abstract] [Full Text] [Related]
9. Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus. Vujcic LK; Shepp DH; Klutch M; Wells MA; Hendry RM; Wittek AE; Krilov L; Quinnan GV J Infect Dis; 1988 May; 157(5):1047-50. PubMed ID: 3162928 [No Abstract] [Full Text] [Related]
10. Salivary immunoglobulin A antibodies to gp41 in human immunodeficiency virus-seropositive patients: lack of correlation with disease progression. Toro MJ; Escalona L; Chaiyarit P; Warner NA; Gregory RL Oral Microbiol Immunol; 2001 Jun; 16(3):188-92. PubMed ID: 11358543 [TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus presence and salivary composition in acquired immunodeficiency syndrome. Marder MZ; Barr CE; Mandel ID Oral Surg Oral Med Oral Pathol; 1985 Oct; 60(4):372-6. PubMed ID: 2997684 [TBL] [Abstract][Full Text] [Related]
12. Human retrovirus infection and immunodeficiencies. Detection and significance of virus-neutralizing antibodies. Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Francavilla E; Amadori A; Chieco-Bianchi L Antibiot Chemother (1971); 1987; 38():159-66. PubMed ID: 3662468 [No Abstract] [Full Text] [Related]
13. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760 [TBL] [Abstract][Full Text] [Related]
14. The concentration of salivary IgA in whole and parotid saliva and the effect of stimulation. Ben-Aryeh H; Naon H; Szargel R; Horowitz G; Gutman D Int J Oral Maxillofac Surg; 1986 Feb; 15(1):81-4. PubMed ID: 3083009 [TBL] [Abstract][Full Text] [Related]
15. Detection and characterization of circulating immune complexes in HIV-related diseases. Carini C; D'Amelio R; Mezzaroma I; Aiuti F Diagn Clin Immunol; 1987; 5(3):135-9. PubMed ID: 3480082 [TBL] [Abstract][Full Text] [Related]
16. Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage. Sun D; Archibald DW; Furth PA AIDS Res Hum Retroviruses; 1990 Jul; 6(7):933-41. PubMed ID: 2117957 [TBL] [Abstract][Full Text] [Related]
17. Detection of HIV antigens in eluates from whole blood collected on filterpaper. Nielsen CM; Bygbjerg IC; Vestergaard BF Lancet; 1987 Mar; 1(8532):566-7. PubMed ID: 2881117 [No Abstract] [Full Text] [Related]
18. AIDS in Sicily: prevalence of antibodies to human immunodeficiency virus (HIV) in low and high risk groups. Vitale F; Portera M; De Crescenzo L; Lupo G; Russo Alesi D; Torregrossa MV; Romano N; Mauro L; Abbadessa V; Mancuso G Eur J Epidemiol; 1987 Sep; 3(3):278-83. PubMed ID: 3498647 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome]. Schulte C; Meurer M; Fröschl M Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727 [TBL] [Abstract][Full Text] [Related]
20. Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status. Schmidt G; Amiraian K; Frey H; Stevens RW; Berns DS J Clin Microbiol; 1987 Oct; 25(10):1993-8. PubMed ID: 2444624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]